RALA/FKBPL: TACKLING OBESITY WITH A NEW NANOMEDICINE front page preview

RALA/FKBPL: TACKLING OBESITY WITH A NEW NANOMEDICINE

Obesity costs the UK economy nearly £47 billion per year. 40–70% of inter-individual variability in BMI attributable to genetic factors. Although treatment strategies are available, the side effects associated with their...

pdf 1.1MB

CDaaS—Clinical Data as a Service  front page preview

CDaaS—Clinical Data as a Service

The Clinical Data as a Service Platform (CDaaS) brings to GPs, surgeons and third parties, synthetized information of PoC diagnosis data, specifically in this case for the detection of acute infection with the identif...

pdf 183.4KB

SensCuff - A Non-Invasive Vascular Monitoring and Diagnostics Technology  front page preview

SensCuff - A Non-Invasive Vascular Monitoring and Diagnostics Technology

Senscuff provides a means with which to non-invasively monitor a user’s vascular health using standard blood pressure cuff technology and acoustic signal analysis.

pdf 347.4KB

Optimal power allocation and sharing algorithm - Licensing Opportunity from University College Cork 2019 front page preview

Optimal power allocation and sharing algorithm - Licensing Opportunity from University College Cork 2019

Optimal power allocation and sharing algorithm for maximizing efficient operation of a parallel multi-unit power conversion system

pdf 138KB

Breast Cancer Biomarkers as a Clinical Management Tool for RCSI June 2019 front page preview

Breast Cancer Biomarkers as a Clinical Management Tool for RCSI June 2019

The global market for ER-positive breast cancer is estimated to be 2.86 billion. Despite availability of effective treatments, survival rates are low in Stage IV as compared to other stages. ADAM22 is a novel therapeutic...

pdf 437.5KB